<DOC>
	<DOCNO>NCT01788930</DOCNO>
	<brief_summary>Type-2 Diabetes Sleep Apnea Syndrome ( SAS ) relate increase platelet activation . Type 2 diabetes often associate sleep apnea syndrome prevalence 60 % . The main objective study analyze influence sleep apnea response antiplatelet therapy stable aspirin-treated type-2 diabetes patient . Consecutive stable aspirin-treated type-2 diabetes patient refer suspicion sleep apnea recruit provide informed consent . Response aspirin assess Verify Now Aspirin ( TM ) rapid analyser morning nocturnal polysomnography , compare group type-2 diabetes free sleep apnea . Other endocrine , metabolic , hematologic cardiovascular confounders also assess baseline determine influence response aspirin . Then , Patients severe SAS ( Apnea-Hypopnea Index &gt; 30 events/h ) response Aspirin ( ARU &gt; 454 ) randomize 3 month active sham continuous positive airway pressure treatment pilot study . After 3-months intervention , response aspirin compare sham effective CPAP group .</brief_summary>
	<brief_title>Aspirin Resistance Sleep Apnea Type-2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<criteria>Men woman age &gt; 18 year old With Type 2 diabetes Stable Atherothrombosis 3 month Using aspirin 10 day without aspirin ( last case , observational study . ) Without modification treatment 10 day Ambulatory patient Without cardiovascular event inflammatory disease 3 month inclusion Pregnant woman Other active clinically significant illness , include unstable cardiovascular , neoplasia could interfere study conduct counterindicate study treatment place patient risk trial compromise study participation Patients participate study Patient without medical care insurance Any treatment could interfere aspirin Previous treatment CPAP</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>